Skip to main content

Drugs

Ausgabe 10/2023

Inhalt (12 Artikel)

Leading Article

New Pharmacologic Approaches to the Treatment of Bipolar Depression

Kamyar Keramatian, Trisha Chakrabarty, Anais DuBow, Gayatri Saraf, Lakshmi N. Yatham

Review Article

Targeting IL-23 for IBD: Rationale and Progress to Date

Sudheer K. Vuyyuru, Lisa M. Shackelton, Jurij Hanzel, Christopher Ma, Vipul Jairath, Brian G. Feagan

Review Article

Acute Graft-versus-Host Disease: An Update on New Treatment Options

Dilan A. Patel, Mallory Crain, Iskra Pusic, Mark A. Schroeder

Open Access Systematic Review

The Effect of Biological Treatment on Fatigue in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Berit Mære Skjellerudsveen, Inger Marie Skoie, Ingvild Dalen, Tore Grimstad, Roald Omdal

Open Access Adis Drug Evaluation

Fenfluramine: A Review in Dravet and Lennox-Gastaut Syndromes

James E. Frampton

AdisInsight Report

Glofitamab: First Approval

Matt Shirley

AdisInsight Report

Leniolisib: First Approval

Sean Duggan, Zaina T. Al-Salama

Open Access Correction

Correction to: Efanesoctocog Alfa: First Approval

Susan J. Keam

Open Access Correction

Correction to: Sparsentan: First Approval

Yahiya Y. Syed

Aktuelle Ausgaben